Tranexamic Acid in Hip Fracture Patients

• Status: Unknown status
• Trial end date: 2013-06-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a randomized controlled trial comparing the use of tranexamic acid to placebo in patients admitted to hospital with a hip fracture.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Michal Roll PhD,MBA
• Collaborator: Tel-Aviv Sourasky Medical Center
• Treatments: Tranexamic Acid

Criteria

Inclusion Criteria:

• Patients admitted to the emergency room with proximal hip fractures (31A-31B according to the Muller AO classification of fractures - long bones).

• Patients mentally capable of giving informed consent.

Exclusion Criteria:

1. Vascular events within the last 2 months such as CVA, TIA, ACS, MI, DVT or arterial thrombosis.

2. Patients receiving anticoagulation therapy with Coumadin or Plavix.

3. Pregnancy and breastfeeding females.

4. Previous arterial or venous thrombosis

5. History of seizures.

6. Creatinine >2.

7. Oestroprogestive therapy.

8. Multiple fractures.